Founded: 2018
Founders: Andrew Livingston, Piers R. J. Gaffney
CEO: Andrew Livingston


Exactmer - lab action

Exactmer develops a cutting-edge technology platform for the synthesis of biopolymers and synthetic polymers in liquid phase.

This innovative technology facilitates the synthesis and separation of molecules via nanofiltration, leveraging size and shape to achieve high efficiency. It enables the isolation of highly pure and specific molecular components with exceptional accuracy and scalability. It is the winner of several grants including from Innovate UK and the European Innovation Council (EIC). Investors include Asahi Kasei Ventures. It is revenue generation and has 30 employees.





Media:

Exactmer awarded with SMART Grant from Innovate UK - Exactmer

Exactmer Awarded £2M for Alternative Oligo Chemistries - Exactmer

Exactmer & Asahi Kasei Partnership for Oligo Manufacturing

Breakthrough in Liquid Phase Oligonucleotide Synthesis: Nanostar Sieving® Enables First Large-Scale, Fully Liquid Process - Exactmer